// App-Quantinova.ai

4361 : Timing of PD-1 blockade is critical to successful synergy with OX40 costimulation in preclinical mammary tumor models

Researchers

Presenter

  • David J. Messenheimer

Principal Investigators

  • Zipei Feng

  • Keith W. Wegmann

  • Shawn M. Jensen

  • Carlo B. Bifulco

  • Bernard A. Fox

Medical Centers

  • Earle A. Chiles Research Institute, Portalnd, OR

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved